Pycnogenol® Trial Findings in Lipedema Patients (2025) Study Design •Type: Randomized, double-blind, placebo-controlled clinical trial. •Participants: 100 women aged 18–40 years with clinically diagnosed lipedema. •Intervention: Pycnogenol® 50 mg three times daily (total ~150 mg/day) vs placebo. •Duration: 60 days (about 2 months). •Outcomes Measured: Lipedema symptoms, quality of life (QuASiL questionnaire), body composition (bioimpedance), and patient-reported changes. 📊 Key Results Symptom R

Mark Kerr Recalls His One & Only Gi Training Session: "Never Again"

Power of Attorney Solicitors Edinburgh & Glasgow – Gibson Kerr